Categories: DiagnosticsFutureHealthTechResearchTechnology
Spear Bio enables laboratories to perform ultrasensitive immunoassays on microsamples at scale.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2024 | Series A | $45M | - |
Mentions in press and media 5
| Date | Title | Description |
| 12.08.2024 | Spear Bio: $45 Million (Series A) Raised To Advance Protein Research And Disease Diagnostics | Spear Bio (a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment) announced the closing of its $45 million Series A financing. This oversubscribed round was co-led by F... |
| 29.07.2024 | Spear Bio Raises $45M in Series A Financing | Spear Bio Inc., a Woburn, MA-based biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, closed a $45m Series A financing.
The round was co-led by Foresite Capital and B... |
| 30.11.2023 | Spear Bio Closes Seed Funding of Tens of Millions of US Dollars | Spear Bio Assay Kit
Spear Bio, a Woburn, MA-based Harvard University biotech spin-off developing scalable solutions for ultrasensitive detection of protein biomarkers, raised tens of millions of US dollars in Seed funding.
The round was led... |
| 15.11.2023 | Deals in brief: Augmentus and Etaily secure Series A funding, SC Ventures launches Libeara, multiple China and India deals, and more | Augmentus secures USD 5 million in Series A round
The Singapore-based no-code robotics software company has secured USD 5 million in a Series A funding round led by Sierra Ventures, along with participation from existing seed investor Cocoo... |
| - | Spear Bio | “Spear Bio enables laboratories to perform ultrasensitive immunoassays on microsamples at scale.” |
Reviews 0
